Clinical Trials Browser

Phase 1 × Multiple Myeloma × Pharmacogenomic Variants × Clear all

NCT03502577 2024-01-08

BCMA-Specific CAR T-Cells Combined With a Gamma Secretase Inhibitor (JSMD194) to Treat Relapsed or Persistent Multiple Myeloma

Phase 1 Terminated

Multiple Myeloma